Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization

Youyun Liang, Tor W. Jensen, Edward J. Roy, Chaenyung Cha, Ross J. DeVolder, Richie E. Kohman, Bao Zhong Zhang, Kyle B. Textor, Lauretta A. Rund, Lawrence B. Schook, Yen Wah Tong, Hyunjoon Kong

Research output: Contribution to journalArticle

Abstract

Injectable and biodegradable hydrogels have been increasingly studied for sustained drug delivery in various molecular therapies. However, it remains a challenge to attain desired delivery rate at injection sites due to local tissue pressures exerted on the soft hydrogels. Furthermore, there is often limited controllability of stiffness and degradation rates, which are key factors required for achieving desired drug release rate and therapeutic efficacy. This study presents a stiff and metastable poly(ethylene glycol) diacrylate (PEGDA)-poly(ethylene imine) (PEI) hydrogel which exhibits an elastic modulus equivalent to bulk plastic materials, and controllable degradation rate independent of its initial elastic modulus. Such unique stiffness was attained from the highly branched architecture of PEI, and the decoupled controllability of degradation rate was achieved by tuning the non-equilibrium swelling of the hydrogel. Furthermore, a single intramuscular administration of granulocyte colony stimulating factor (GCSF)-encapsulated PEGDA-PEI hydrogel extended the mobilization of mononuclear cells to four days. A larger yield of expanded CD34+ and CD31+ endothelial progenitor cells (EPCs) was also obtained as compared to the daily bolus administration. Overall, the hydrogel created in this study will be useful for the controlled and sustained delivery of a wide array of drug molecules.

Original languageEnglish (US)
Pages (from-to)2004-2012
Number of pages9
JournalBiomaterials
Volume32
Issue number7
DOIs
StatePublished - Mar 1 2011

Fingerprint

Hematopoietic Stem Cell Mobilization
Ethylene Glycol
Hydrogel
Hydrogels
Polyethylene glycols
Stem Cells
Tuning
Elastic Modulus
Controllability
Degradation
Pharmaceutical Preparations
Ethylene
Elastic moduli
Stiffness
Injections
Endothelial cells
Granulocyte Colony-Stimulating Factor
Drug delivery
Plastics
Swelling

Keywords

  • Degradation rate
  • Granulocyte colony stimulating factor (GCSF)
  • Michael-Addition
  • Poly(ethyleneimine)
  • Rigidity

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization. / Liang, Youyun; Jensen, Tor W.; Roy, Edward J.; Cha, Chaenyung; DeVolder, Ross J.; Kohman, Richie E.; Zhang, Bao Zhong; Textor, Kyle B.; Rund, Lauretta A.; Schook, Lawrence B.; Tong, Yen Wah; Kong, Hyunjoon.

In: Biomaterials, Vol. 32, No. 7, 01.03.2011, p. 2004-2012.

Research output: Contribution to journalArticle

Liang, Youyun ; Jensen, Tor W. ; Roy, Edward J. ; Cha, Chaenyung ; DeVolder, Ross J. ; Kohman, Richie E. ; Zhang, Bao Zhong ; Textor, Kyle B. ; Rund, Lauretta A. ; Schook, Lawrence B. ; Tong, Yen Wah ; Kong, Hyunjoon. / Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization. In: Biomaterials. 2011 ; Vol. 32, No. 7. pp. 2004-2012.
@article{ffd7cf5d59b8457c877440c8fa03cd60,
title = "Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization",
abstract = "Injectable and biodegradable hydrogels have been increasingly studied for sustained drug delivery in various molecular therapies. However, it remains a challenge to attain desired delivery rate at injection sites due to local tissue pressures exerted on the soft hydrogels. Furthermore, there is often limited controllability of stiffness and degradation rates, which are key factors required for achieving desired drug release rate and therapeutic efficacy. This study presents a stiff and metastable poly(ethylene glycol) diacrylate (PEGDA)-poly(ethylene imine) (PEI) hydrogel which exhibits an elastic modulus equivalent to bulk plastic materials, and controllable degradation rate independent of its initial elastic modulus. Such unique stiffness was attained from the highly branched architecture of PEI, and the decoupled controllability of degradation rate was achieved by tuning the non-equilibrium swelling of the hydrogel. Furthermore, a single intramuscular administration of granulocyte colony stimulating factor (GCSF)-encapsulated PEGDA-PEI hydrogel extended the mobilization of mononuclear cells to four days. A larger yield of expanded CD34+ and CD31+ endothelial progenitor cells (EPCs) was also obtained as compared to the daily bolus administration. Overall, the hydrogel created in this study will be useful for the controlled and sustained delivery of a wide array of drug molecules.",
keywords = "Degradation rate, Granulocyte colony stimulating factor (GCSF), Michael-Addition, Poly(ethyleneimine), Rigidity",
author = "Youyun Liang and Jensen, {Tor W.} and Roy, {Edward J.} and Chaenyung Cha and DeVolder, {Ross J.} and Kohman, {Richie E.} and Zhang, {Bao Zhong} and Textor, {Kyle B.} and Rund, {Lauretta A.} and Schook, {Lawrence B.} and Tong, {Yen Wah} and Hyunjoon Kong",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.biomaterials.2010.11.021",
language = "English (US)",
volume = "32",
pages = "2004--2012",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "7",

}

TY - JOUR

T1 - Tuning the non-equilibrium state of a drug-encapsulated poly(ethylene glycol) hydrogel for stem and progenitor cell mobilization

AU - Liang, Youyun

AU - Jensen, Tor W.

AU - Roy, Edward J.

AU - Cha, Chaenyung

AU - DeVolder, Ross J.

AU - Kohman, Richie E.

AU - Zhang, Bao Zhong

AU - Textor, Kyle B.

AU - Rund, Lauretta A.

AU - Schook, Lawrence B.

AU - Tong, Yen Wah

AU - Kong, Hyunjoon

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Injectable and biodegradable hydrogels have been increasingly studied for sustained drug delivery in various molecular therapies. However, it remains a challenge to attain desired delivery rate at injection sites due to local tissue pressures exerted on the soft hydrogels. Furthermore, there is often limited controllability of stiffness and degradation rates, which are key factors required for achieving desired drug release rate and therapeutic efficacy. This study presents a stiff and metastable poly(ethylene glycol) diacrylate (PEGDA)-poly(ethylene imine) (PEI) hydrogel which exhibits an elastic modulus equivalent to bulk plastic materials, and controllable degradation rate independent of its initial elastic modulus. Such unique stiffness was attained from the highly branched architecture of PEI, and the decoupled controllability of degradation rate was achieved by tuning the non-equilibrium swelling of the hydrogel. Furthermore, a single intramuscular administration of granulocyte colony stimulating factor (GCSF)-encapsulated PEGDA-PEI hydrogel extended the mobilization of mononuclear cells to four days. A larger yield of expanded CD34+ and CD31+ endothelial progenitor cells (EPCs) was also obtained as compared to the daily bolus administration. Overall, the hydrogel created in this study will be useful for the controlled and sustained delivery of a wide array of drug molecules.

AB - Injectable and biodegradable hydrogels have been increasingly studied for sustained drug delivery in various molecular therapies. However, it remains a challenge to attain desired delivery rate at injection sites due to local tissue pressures exerted on the soft hydrogels. Furthermore, there is often limited controllability of stiffness and degradation rates, which are key factors required for achieving desired drug release rate and therapeutic efficacy. This study presents a stiff and metastable poly(ethylene glycol) diacrylate (PEGDA)-poly(ethylene imine) (PEI) hydrogel which exhibits an elastic modulus equivalent to bulk plastic materials, and controllable degradation rate independent of its initial elastic modulus. Such unique stiffness was attained from the highly branched architecture of PEI, and the decoupled controllability of degradation rate was achieved by tuning the non-equilibrium swelling of the hydrogel. Furthermore, a single intramuscular administration of granulocyte colony stimulating factor (GCSF)-encapsulated PEGDA-PEI hydrogel extended the mobilization of mononuclear cells to four days. A larger yield of expanded CD34+ and CD31+ endothelial progenitor cells (EPCs) was also obtained as compared to the daily bolus administration. Overall, the hydrogel created in this study will be useful for the controlled and sustained delivery of a wide array of drug molecules.

KW - Degradation rate

KW - Granulocyte colony stimulating factor (GCSF)

KW - Michael-Addition

KW - Poly(ethyleneimine)

KW - Rigidity

UR - http://www.scopus.com/inward/record.url?scp=78650993581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650993581&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2010.11.021

DO - 10.1016/j.biomaterials.2010.11.021

M3 - Article

C2 - 21144582

AN - SCOPUS:78650993581

VL - 32

SP - 2004

EP - 2012

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 7

ER -